Evidence and analysis
Latest Market Data
| Metric | Current value |
|---|---|
| Product type | ETF |
| ETF market price (USD) | $311.90 |
| Observation date | 2026-10-02 (US Eastern Time) |
| 52-week range (USD) | $263.00 – $330.75 |
| Adjusted-close return over retrieved year | +17.57% |
| Annualised observed return | +17.63% |
| Annualised daily volatility | 15.21% |
| History window | 2025-10-03 to 2026-10-02 |
| Daily observations | 251 |
Source: Yahoo Finance, retrieved 2026-10-05. ETF market prices differ from NAV. Return is computed from adjusted closes; annualisation uses 365.25 divided by elapsed calendar days. Volatility is the sample standard deviation of daily simple adjusted-close returns multiplied by √252. These are historical observations, not forecast returns. Key facts, holdings, sector weights and other older analysis retain their original source dates and were not refreshed by this market-data update.
Vanguard Health Care ETF
The Vanguard Health Care ETF (VHT) provides exposure to companies in the healthcare sector. It tracks the MSCI US Investable Market Health Care 25/50 Index, covering pharmaceutical companies, biotechnology firms, medical device manufacturers, healthcare providers, and life science tools companies.
Key Features:
- Healthcare Sector Exposure: Broad coverage across healthcare subsectors
- Innovation Exposure: Access to companies driving medical innovation
- Defensive Characteristics: Healthcare demand is relatively inelastic
- Diversified Holdings: Major holdings include UnitedHealth, Eli Lilly, Johnson & Johnson, and Pfizer
Expense Ratio: 0.10%
Number of Holdings | 429
Portfolio Context:
VHT is the closest Vanguard equivalent to the Global Healthcare Fund.
This ETF is part of the Vanguard ETF Portfolio vs Equivalent Fidelity Funds comparison, where it serves as the Vanguard equivalent for one or more Fidelity funds.
Top Holdings
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Eli Lilly and Co | LLY | 13.99% |
| 2 | Johnson & Johnson | JNJ | 8.44% |
| 3 | AbbVie Inc | ABBV | 6.07% |
| 4 | UnitedHealth Group Inc | UNH | 5.44% |
| 5 | Merck & Co Inc | MRK | 4.63% |
| 6 | Thermo Fisher Scientific Inc | TMO | 2.88% |
| 7 | Amgen Inc | AMGN | 2.86% |
| 8 | Gilead Sciences Inc | GILD | 2.63% |
| 9 | Intuitive Surgical Inc | ISRG | 2.38% |
| 10 | Abbott Laboratories | ABT | 2.35% |
Sector Allocation
| Sector | Weight |
|---|---|
| Health Care | 100.0% |
Note: This is an informational overview for educational purposes. Past performance does not guarantee future results. Consider your investment objectives, risk tolerance, and fees before investing.